BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26505456)

  • 21. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG; Gonzalez D; Shah P; Pynegar MJ; Deshmukh M; Rice A; Popat S
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combination of circulating tumor cells with serum carcinoembryonic antigen enhances clinical prediction of non-small cell lung cancer.
    Chen X; Wang X; He H; Liu Z; Hu JF; Li W
    PLoS One; 2015; 10(5):e0126276. PubMed ID: 25996878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant protein gene expressions for detection of lung carcinoma cells in peripheral blood.
    Yamamoto O; Takahashi H; Hirasawa M; Chiba H; Shiratori M; Kuroki Y; Abe S
    Respir Med; 2005 Sep; 99(9):1164-74. PubMed ID: 16085219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients.
    Pelosi G; Schianchi E; Dell'orto P; Veronesi G; Spaggiari L; Pasini F; Sozzi G; Brambilla E; Griso C; Viale G
    Virchows Arch; 2006 Jan; 448(1):7-15. PubMed ID: 16193293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The detection of circulating tumor cells of breast cancer patients by using multimarker (Survivin, hTERT and hMAM) quantitative real-time PCR.
    Shen C; Hu L; Xia L; Li Y
    Clin Biochem; 2009 Feb; 42(3):194-200. PubMed ID: 19022237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancer.
    Zhu CQ; Cutz JC; Liu N; Lau D; Shepherd FA; Squire JA; Tsao MS
    Br J Cancer; 2006 May; 94(10):1452-9. PubMed ID: 16641908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer.
    Chong IW; Chang MY; Chang HC; Yu YP; Sheu CC; Tsai JR; Hung JY; Chou SH; Tsai MS; Hwang JJ; Lin SR
    Oncol Rep; 2006 Nov; 16(5):981-8. PubMed ID: 17016581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of enrichment and detection of circulating tumor cells in NSCLC patients with immunomagnetic beads].
    Huang TH; Wang Z; Li Q; Li FR; Qi H; Zhou HX
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):676-80. PubMed ID: 18246797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amplification and overexpression of SKP2 are associated with metastasis of non-small-cell lung cancers to lymph nodes.
    Yokoi S; Yasui K; Mori M; Iizasa T; Fujisawa T; Inazawa J
    Am J Pathol; 2004 Jul; 165(1):175-80. PubMed ID: 15215173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of overexpression of Skp2 mRNA in non-small cell lung cancer.
    Takanami I
    Oncol Rep; 2005 Apr; 13(4):727-31. PubMed ID: 15756449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of RIN1 gene expression in human non-small cell lung cancer.
    Wang Q; Gao Y; Tang Y; Ma L; Zhao M; Wang X
    Acta Histochem; 2012 Sep; 114(5):463-8. PubMed ID: 21925717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination of four gene markers to detect circulating tumor cells in the peripheral blood of patients with advanced lung adenocarcinoma using real-time PCR.
    Yu Y; Xu G; Cao J; Jin S; Man Y; Shang L
    Oncol Lett; 2013 Apr; 5(4):1400-1406. PubMed ID: 23599802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
    Myong NH
    J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project.
    Van den Berg RM; Brokx H; Vesin A; Field JK; Brambilla C; Meijer CJ; Sutedja GT; Heideman DA; Postmus PE; Smit EF; Snijders PJ
    Int J Oncol; 2010 Aug; 37(2):455-61. PubMed ID: 20596673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
    Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
    Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of CK19, LUNX, and KS1/4 mRNA expression in the peripheral blood for diagnosis of micrometastases in patients with non-small cell lung cancer and their clinical implications.
    Yan L; Yao Y; Wang LH; Wang ML; Fu XH
    Genet Mol Res; 2015 Nov; 14(4):15090-5. PubMed ID: 26634471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection and prognostic value of epithelial markers mRNA expression in peripheral blood of advanced non-small cell lung cancer patients.
    Arrieta O; Pineda B; Muñiz-Hernández S; Flores D; Ordóñez G; Borbolla-Escoboza JR; Orta D
    Cancer Biomark; 2014; 14(4):215-23. PubMed ID: 24934364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.